Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target (2022)
- Authors:
- Moraes, Beatriz Caroline de
- Ribeiro Filho, Helder Veras
- Roldão, Allan Pradelli
- Toniolo, Elaine Flamia
- Carretero, Gustavo Penteado Battesini
- Sgro, Germán Gustavo
- Batista, Fernanda A. H
- Berardi, Damian E
- Oliveira, Victoria Regina da Silva
- Tomasin, Rebeka
- Vieceli, Felipe Monteleone
- Pramio, Dimitrius Tansini
- Bruni-Cardoso, Alexandre
- Figueira, Ana C. M
- Farah, Chuck Shaker
- Devi, Lakshmi A.
- Dale, Camila Squarzoni
- Oliveira, Paulo S. L. de
- Schechtman, Deborah
- Moraes, Beatriz Caroline de
- USP affiliated authors: SGRO, GERMÁN GUSTAVO - FCFRP ; CARDOSO, ALEXANDRE BRUNI - IQ ; FARAH, SHAKER CHUCK - IQ ; DALE, CAMILA SQUARZONI - ICB ; SCHECHTMAN, DEBORAH - IQ ; MORAES, BEATRIZ CAROLINE DE - IQ ; ROLDÃO, ALLAN PRADELLI - IQ ; CARRETERO, GUSTAVO PENTEADO BATTESINI - IQ ; OLIVEIRA, VICTORIA REGINA DA SILVA - ICB ; TOMASIN, REBEKA - IQ ; VIECELI, FELIPE MONTELEONE - IQ ; TONIOLO, ELAINE FLAMIA - ICB
- Unidades: FCFRP; IQ; ICB
- DOI: 10.1126/scisignal.abm6046
- Subjects: DOR CRÔNICA; ANALGÉSICOS; ANATOMIA; FOSFOLIPASES; MUTAÇÃO GENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2022
- Source:
- Título: Science Signaling
- ISSN: 1945-0877
- Volume/Número/Paginação/Ano: v. 15, n. 731, p. 1-16, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MORAES, Beatriz Caroline de et al. Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target. Science Signaling, v. 15, n. 731, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1126/scisignal.abm6046. Acesso em: 10 fev. 2026. -
APA
Moraes, B. C. de, Ribeiro Filho, H. V., Roldão, A. P., Toniolo, E. F., Carretero, G. P. B., Sgro, G. G., et al. (2022). Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target. Science Signaling, 15( 731), 1-16. doi:10.1126/scisignal.abm6046 -
NLM
Moraes BC de, Ribeiro Filho HV, Roldão AP, Toniolo EF, Carretero GPB, Sgro GG, Batista FAH, Berardi DE, Oliveira VR da S, Tomasin R, Vieceli FM, Pramio DT, Bruni-Cardoso A, Figueira ACM, Farah CS, Devi LA, Dale CS, Oliveira PSL de, Schechtman D. Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target [Internet]. Science Signaling. 2022 ; 15( 731): 1-16.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1126/scisignal.abm6046 -
Vancouver
Moraes BC de, Ribeiro Filho HV, Roldão AP, Toniolo EF, Carretero GPB, Sgro GG, Batista FAH, Berardi DE, Oliveira VR da S, Tomasin R, Vieceli FM, Pramio DT, Bruni-Cardoso A, Figueira ACM, Farah CS, Devi LA, Dale CS, Oliveira PSL de, Schechtman D. Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target [Internet]. Science Signaling. 2022 ; 15( 731): 1-16.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1126/scisignal.abm6046 - New analgesic lead developed based on analysis of mutations in patients with congenital insensitivity to pain
- Structure-activity analysis of the TrkA - PLCγ interaction and the development of inhibitors that play an analgesic role based on such interaction
- Pten is a disconnecting node in the molecular landscape of the proliferation/quiescence decision during mammary gland acinogenesis
- The role of cellular quiescence in cancer – beyond a quiet passenger
- Binding specificity assessment of SH2 domains present in PLCgamma for peptides derived from tyrosines kinases
- Effect of photobiomodulation on neuropathic pain of diabetic origin: a narrative review of the literature
- Preoperative pulmonary ultrasound: a valuable tool for managing post-COVID-19 sequelae
- Endothelial cell responses to pPhotobiomodulation treatments in diabetic wounds are mediated via concerted PDGF, VEGF and TGF-β signalling
- Establishment of PLCg as a target for covalent fragment‐based drug discovery
- Análise de mutações genéticas leva à descoberta de novo alvo para o desenvolvimento de analgésicos [Depoimento]
Informações sobre o DOI: 10.1126/scisignal.abm6046 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3076837.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
